Abstract
Epigenetic reprogramming is a cornerstone of immune memory, shaping both innate (trained immunity) and adaptive immune responses following Bacillus Calmette-Guérin (BCG) vaccination. While the role of histone modifications is well-documented, the impact of dynamic DNA methylation (DNAm) on long-term immunological traits has remained less clear. This study utilizes a longitudinal systems biology approach to analyze a cohort of 284 healthy individuals, integrating genetic, epigenetic, and cytokine response data at baseline, 14 days, and 90 days post-vaccination. Our findings reveal distinct short- and long-term DNAm patterns and identify baseline DNAm profiles as predictors of interferon-γ (IFN-γ) production. Notably, we identify the kisspeptin pathway as a novel regulator of IFN-γ and demonstrate that DNAm changes act as a critical mediator between genetic variants and cytokine responses. These results provide a deeper understanding of the mechanisms underlying trained immunity and highlight the importance of sex-specific effects in vaccine responses.
Introduction
The Bacillus Calmette-Guérin (BCG) vaccine, originally developed for tuberculosis, is recognized for its ability to provide heterologous protection against unrelated infections. This phenomenon, termed "trained immunity," is driven by the functional reprogramming of innate immune cells. While previous research has focused heavily on transient histone modifications, the role of DNA methylation—a more stable and potentially heritable epigenetic mark—in sustaining these immune traits has been inadequately elucidated.
This study addresses this knowledge gap by investigating how BCG vaccination alters the DNA methylome over time and how these alterations influence the body's ability to mount cytokine responses against non-target pathogens like Staphylococcus aureus. By mapping the interplay between genetics, epigenetics, and immune function, we aim to uncover the regulatory architecture of human trained immunity.
Methodology
We conducted a comprehensive analysis using the 300BCG cohort, consisting of 284 healthy Dutch individuals. Data were collected at three critical time points: baseline (T0), 14 days (T14), and 90 days (T90) post-vaccination.
Multi-omics Integration
To capture a holistic view of the immune landscape, we integrated:
- Genome-wide DNA Methylation: Measured using Illumina EPIC arrays.
- Genetics: Single Nucleotide Polymorphism (SNP) data to identify methylation quantitative trait loci (mQTLs).
- Cytokine Profiling: Ex vivo stimulation of whole blood with S. aureus to measure the production of IL-1β, IL-6, TNF-α, and IFN-γ.
Statistical and Experimental Validation
We employed mediation analysis to determine if DNAm changes serve as a bridge between genetic predispositions and observed cytokine outputs. Furthermore, we performed in vitro validation of the kisspeptin pathway—a novel finding from our epigenetic screen—to confirm its functional role in modulating IFN-γ production.
Key Insights and Results
The Dynamic Nature of DNA Methylation
Our longitudinal analysis revealed that BCG-induced DNAm changes are not static. We observed a "recovery phase" at T14, where many methylation sites briefly trended back toward baseline, followed by the emergence of a distinct "late" signature at T90. This suggests that the epigenetic "memory" of the vaccine matures over months, rather than being fully established in the immediate aftermath of vaccination.
Kisspeptin: A Novel Immune Regulator
One of the most significant discoveries was the involvement of the kisspeptin (KISS1) receptor system. Traditionally known for its role in reproductive health and puberty, our data indicated that kisspeptin signaling is a potent modulator of the immune response. In vitro experiments confirmed that kisspeptin significantly inhibits IFN-γ production, identifying it as a previously unrecognized checkpoint in heterologous immunity.
Bridging Genetics and Immunity
Mediation analysis demonstrated that DNA methylation is a primary mechanism through which genetic variation influences vaccine response. For instance, we identified that changes at the cg21375332 site (near the SLC12A3 gene) mediate the relationship between specific genetic variants and the magnitude of the IFN-γ response after vaccination. In total, 18 unidirectional mediation linkages were identified, proving that persistent epigenetic modifications regulate cytokine production in both monocytes and T cells.
Predictive Modeling and Sex Differences
By combining baseline DNAm profiles with metabolic data, we could explain 56.1% of the variance in IFN-γ production at day 90. Interestingly, these responses were highly sex-specific. In women, short-term DNAm changes were associated with hormone-related pathways (e.g., GnRH), whereas in men, changes were more closely linked to nervous system pathways. This highlights the necessity of considering sex as a biological variable in vaccine research.
Discussion and Limitations
While this study provides a high-resolution map of the epigenetic changes following BCG vaccination, several limitations remain. The Illumina EPIC array, while robust, covers only ~3% of the human methylome, potentially missing regulatory events in non-covered regions. Additionally, because the analysis was performed on whole blood, cell-type-specific contributions (e.g., from specific monocyte subsets vs. T cells) require further investigation using single-cell technologies.
Despite these limitations, our findings underscore that DNA methylation is a stable, mediating layer that translates genetic potential into functional immune outcomes. This work paves the way for "personalized vaccinology," where baseline epigenetic signatures could be used to predict how an individual will respond to vaccination or to develop targeted interventions to enhance trained immunity in vulnerable populations.
Summary updated